Cochrane Database of Systematic Reviews 2008
DOI: 10.1002/14651858.cd007248
|View full text |Cite
|
Sign up to set email alerts
|

Propofol for procedural sedation/anesthesia in neonates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 19 publications
1
3
0
Order By: Relevance
“…However, levels reached baseline preinduction levels within 24 h. At no point of time after 90 min did hypertriglyceridemia occur in any of the patients (defined as 150% of upper normal limit, i.e., 270 mg·dl −1 ) nor were there any relevant clinical manifestations. In agreement with us, several studies recorded a significant rise in TG levels, although not reaching the level of hypertriglyceridemia.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…However, levels reached baseline preinduction levels within 24 h. At no point of time after 90 min did hypertriglyceridemia occur in any of the patients (defined as 150% of upper normal limit, i.e., 270 mg·dl −1 ) nor were there any relevant clinical manifestations. In agreement with us, several studies recorded a significant rise in TG levels, although not reaching the level of hypertriglyceridemia.…”
Section: Discussionsupporting
confidence: 90%
“…Propofol has come to be used extensively for induction and maintenance of anesthesia in the pediatric age group, the minimum age group being lowered further with passing time. Its use is now being considered in neonates.…”
Section: Discussionmentioning
confidence: 99%
“…In the central nervous system, propofol induces a dose-dependent suppression of awareness. Prolonged sedation with propofol may cause neurologic sequelae in children [39], [71], and [12] and short-term sedation may cause convulsions [24], [58] and [74]. The mechanisms of propofol action and potential toxicity have been studied in vitro; however, results have been conflicting (i.e., clinical levels may be without effect in some systems but not others, and different endpoints used among studies do not permit direct comparisons) [65].…”
Section: Model Cell Types and Neurotoxicantsmentioning
confidence: 99%
“…The main four types release either chlorhexidine/sulphadiazine, antibiotic substances, heparin, or silver ions. Although evidence of their effect on reducing catheter colonization, CRBSI, or both is good, results to their effect on the different levels of CVC‐borne infection and results of head‐to‐head comparisons of antimicrobial CVCs with different coatings lack consistency …”
Section: Introductionmentioning
confidence: 99%